Is NAMSW or NATR more undervalued in 2026?

CirclFi compares NewAmsterdam Pharma Company N.V (NAMSW) and Nature's Sunshine Products, Inc (NATR) using 13 institutional-grade valuation models. NAMSW has a Quality of Company score of 2.2/10 while NATR scores 8.8/10.

Which is a better buy — NAMSW or NATR?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NAMSW and NATR valuations compare?

NAMSW at $25.00 and NATR at $21.28 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NAMSW vs NATR Valuation Comparison 2026 — Intrinsic Value Analysis

NAMSW

Pharmaceutical Preparations

NewAmsterdam Pharma Company N.V

Quality

2.2

out of 10

Value Trap

—

Price

$25.00

Last close

Models

8/13

Active

NATR

Pharmaceutical Preparations

Nature's Sunshine Products, Inc

Quality

8.8

out of 10

Value Trap

SAFE

Price

$21.28

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	NAMSW Fair Value	NAMSW Upside	NATR Fair Value	NATR Upside
Bayesian DCF	Intrinsic	—	—	$19.61	-7.8%
Earnings Power Value	Intrinsic	—	—	$14.30	-32.8%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$3.60	-83.1%	$17.68	-16.9%
Dynamic NAV	Asset-Based	$6.79	-68.0%	$5.94	-72.1%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NAMSW vs NATR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NAMSW vs NATR — Which Stock Is More Undervalued?

NATR scores higher with a 8.8/10 quality rating vs NAMSW's 2.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing NewAmsterdam Pharma Company N.V (NAMSW) and Nature's Sunshine Products, Inc (NATR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NAMSW currently trades at $25.00 with a QOC of 2.2/10, while NATR trades at $21.28 with a QOC of 8.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).